Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink | CPRD

Publication Type:

Journal Article

Authors:

Matthews, A.; Langan, S. M.; Douglas, I. J.; Smeeth, L.; Bhaskaran, K.

Source:

PLoS Med, Volume 13, Number 6, p.e1002037 (2016)